Systemic Inflammation Increases Intestinal Permeability During Experimental Human Endotoxemia

Abstract

Although the gut is often considered the motor of sepsis, the relation between systemic inflammation and intestinal permeability in humans is not clear. We analyzed intestinal permeability during experimental endotoxemia in humans. Before and during experimental endotoxemia (Escherichia coli LPS, 2 ng/kg), using polyethylene glycol (PEG) as a permeability marker, intestinal permeability was analyzed in 14 healthy subjects. Enterocyte damage was determined by intestinal fatty acid binding protein. Endotoxemia induced an inflammatory response. Urinary PEGs 1,500 and 4,000 recovery increased from 38.8 +/- 6.3 to 63.1 +/- 12.5 and from 0.58 +/- 0.31 to 3.11 +/- 0.93 mg, respectively (P < 0.05). Intestinal fatty acid binding protein excretion was not affected by endotoxemia. The peak serum IL-10 concentrations correlated with the increase in PEG 1,500 recovery (r = 0.48, P = 0.027). Systemic inflammation results in an increased intestinal permeability. The increase in intestinal permeability is most likely caused by inflammation-induced paracellular permeability, rather than ischemia-mediated enterocyte damage.

A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids

“…LPS increases the permeability of Caco-2 cells when administered to the basolateral side (12). In humans, systemically given LPS increases intestinal permeability (13). These reports provide a basis for the claim that LPS aggravates barrier dysfunction and is involved in the pathogenesis of disorders related to a leaky gut but is not involved in the initiation of luminally derived barrier dysfunction.…”

Human Leukocyte Antigen Class II Transgenic Mouse Model Unmasks the Significant Extrahepatic Pathology in Toxic Shock Syndrome

“…Increased gut permeability is well documented in humans during endotoxemia and other systemic inflammatory conditions such as pancreatitis. 68,69 Similarly, altered gut permeability could have an important role in the pathogenesis of TSS in humans. Further studies are needed to address these issues, and the described HLA-II transgenic mouse model will be a valuable tool for dissection of the immunopathogenesis of TSS.…”

Diagnosis biomarkers in acute intestinal ischemic injury: so close, yet so far

“…The disruption of the epithelial barrier resulting from mucosal alterations leads to interactions among microorganisms, bacterial antigens, endotoxins of the intestinal lumen with the mucosal and submucosal immune system. The stimulation of innate immunity will result in local then systemic inflammatory pathways activation such as TLR, NF-κB or TNF [13,14]. Through the bloodstream, bacteria, endotoxins, cells degradation products and activated immune cells translocate and promote SIRS.…”